13.2K subscribers
3 photos
1 video
53.3K links
🔮Science Updates Daily!
🔮Every post with Source Link!
🔮This is 24/7 Working Channel!
🔮Each post is shared from Renowned Websites!

Buy ads: https://telega.io/c/Science_News_Facts_Updates_daily

admin : @The_Lawliet
Download Telegram
Landmark 14-year study found artificially sweetened drinks raise risk of developing type 2 diabetes by more than a third, significantly higher than those with sugar. It challenges long-standing perception diet drinks are a healthier alternative and suggests they may carry their own metabolic risks. 🥤📊⚠️

Read Full Article

#Type2Diabetes #ArtificialSweeteners #DietDrinks #MetabolicHealth #NutritionFacts
Scientists have identified a protein that acts as a traffic controller for fat inside cells, revealing a mechanism that could help explain how the body regulates energy storage 🧬💡 | The discovery provides a new avenue for treating obesity 🍔⚖️ and type 2 diabetes 🍭💉.

Read Full Article

#FatRegulation #ObesityResearch #Type2Diabetes #EnergyStorage #HealthScience
👍1
There's new evidence that cruciferous vegetables (broccoli 🥦, cabbage 🥬, cauliflower 🥗 and kale 🌿) blunt spikes in blood sugar levels, which could be particularly important for those with type 2 diabetes or who are at risk, finds small randomized controlled trial of 4 serves a day over 2 weeks.

Read Full Article

#CruciferousVegetables #BloodSugarControl #Type2Diabetes #HealthyEating #NutritionResearch
❤1
Magnetic field therapy shows promise in mimicking exercise benefits for type 2 diabetes patients with central obesity: Pulsed electromagnetic fields stimulate muscle tissue mimicking the effects of exercise, study finds ⚡🧘‍♂️💪📈

Read Full Article

#MagneticFieldTherapy #Type2Diabetes #PulsedElectromagneticFields #ExerciseMimicking #HealthInnovation
A global study engaged 850,000 adults from six continents and identified 13 obesity-associated genes. Several of these genes also contribute to other obesity-related conditions such as Type 2 diabetes, hypertension, and heart disease. 🌍👥🧬🍔💔

Read Full Article

#ObesityResearch #HealthGenetics #Type2Diabetes #HeartHealth #PublicHealth
Root canal treatment could significantly lower blood sugar levels, suggesting it could protect against type 2 diabetes. Dentists also saw improvements in cholesterol and fatty acid levels. Given broader health impact of tooth infections, oral health should be integrated into general healthcare. 🦷💉🍏✨

Read Full Article

#RootCanalTreatment #OralHealth #Type2Diabetes #Cholesterol #OverallHealth
👎1
New clinical trial involving more than 1,600 people with type 2 diabetes has found that a GLP-1 pill form of the drug orforglipron is similarly effective for weight loss as injectable semaglutide such as Ozempic 💊📉

Read Full Article

#Type2Diabetes #WeightLoss #GLP1 #ClinicalTrial #Orforglipron
❤1
New study suggests a high consumption of food preservatives 🥫 increased the risk of type 2 diabetes 🍩 by almost 50%. This is the first study in the world 🌍 on the links between preservative additives and the incidence of type 2 diabetes.

Read Full Article

#FoodPreservatives #Type2Diabetes #HealthStudy #NutritionAwareness #DiabetesRisk
😨1
Analysis of 100,000 Adults Links Common Preservatives—Specifically Nitrites and Potassium Sorbate—to Higher Risks of Prostate Cancer and Type 2 Diabetes. 🔍📊⚠️

Read Full Article

#HealthResearch #ProstateCancer #Type2Diabetes #FoodAdditives #PublicHealth
😱1
Science News
Triple-action diabetes jab shown to reduce blood sugar and body weight. Retatrutide is designed to control appetite and blood sugar but also increase body’s energy expenditure, unlike other drugs. The triple hormone drug mimics three gut hormones: GLP-1, GIP…
💉 Phase 3 trial results show retatrutide, a new triple-action weekly jab for type 2 diabetes, significantly reduces blood sugar and body weight. Patients lost over 4x more weight and saw over 2x greater blood sugar reduction (HbA1c) compared to placebo after 40 weeks.

⚖️ The drug mimics three gut hormones (GLP-1, GIP, glucagon) to control appetite, blood sugar, and metabolism, also increasing energy expenditure. This differentiates it from drugs like Ozempic, Wegovy, and Mounjaro.

📊 In the study of 930 adults, retatrutide led to average HbA1c drops of 1.7-1.9 percentage points (vs. 0.8 for placebo) and average weight loss of 11.5%-15.3% (vs. 2.6% for placebo). Cholesterol and blood pressure also improved.

📈 Experts call the findings "very encouraging" and "striking," noting the potential for life-changing benefits for those with diabetes and obesity. However, head-to-head trials are needed to compare retatrutide's effectiveness with existing therapies.

#Type2Diabetes #WeightLoss #DiabetesTreatment
Largest clinical trial of its kind, published in the New England Journal of Medicine, finds continuous glucose monitors help adults with type 2 diabetes who don't use insulin spend approximately 5 more hours a day in their target blood sugar range

Read Full Article

#DiabetesManagement #CGM #Type2Diabetes
❤2
Science News
More than half of people with early-onset type 2 diabetes (average age just 38) went into remission with no meds after a 24-week program: 12 weeks of 800–900 calories a day plus supervised strength and cardio workouts. They lost fat but kept their muscle,…
✨ New research suggests type 2 diabetes may not be a lifelong diagnosis.
A combined low-calorie diet (800-900 kcal/day) and supervised exercise program (twice-weekly aerobic/resistance training) put over 50% of early-onset type 2 diabetes patients into remission in a 24-week trial involving 96 participants in Canada and the UK.

💪 Participants in the intervention group achieved remission in 27 out of 50 individuals, compared to only two in the control group. This intervention, led by Kaberi Dasgupta at McGill University, also improved cardiovascular health and preserved muscle mass.

🔬 The study, published in The Lancet Regional Health – Americas, highlights the potential of lifestyle changes for clinically meaningful remission and holistic health benefits, even in early-onset cases of diabetes, often diagnosed at 45 or younger.

#DiabetesRemission #Type2Diabetes #HealthResearch